Phase IIa Clinical Trial of Trans-1-Amino-3-(18)F-Fluoro-Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

OBJECTIVE(S): We performed a phase IIa clinical trial of trans-1-amino-3-(18)F-fluoro-cyclobutane carboxylic acid (anti-(18)F-FACBC), a synthetic amino acid analog for PET, in patients with metastatic prostate cancer. METHODS: The study subjects consisted of 10 untreated prostate cancer patients hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Yusuke, Asano, Yuji, Satoh, Takefumi, Tabata, Ken-ichi, Kikuchi, Kei, Woodhams, Reiko, Baba, Shiro, Hayakawa, Kazushige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Oceania Journal of Nuclear Medicine & Biology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937703/
https://www.ncbi.nlm.nih.gov/pubmed/27408864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937703/
https://www.ncbi.nlm.nih.gov/pubmed/27408864

Ejemplares similares